top of page

Cardiac Arrhythmia Monitoring for Clinicians and Healthcare Professionals

image (25) (1).png

CXDX is the exclusive Australian and New Zealand distributor of the PulseOn Arrhythmia Monitor System (ARTG#519567) – a wrist-worn device that assists in the diagnosis, screening and monitoring of atrial fibrillation and other cardiac arrhythmias visible in Lead I ECG. For use by medical professionals.

Speak to our team directly
Mon–Fri, AEST

The PulseOn Arrhythmia Monitor System is included in the Australian Register of Therapeutic Goods (ARTG number 519567)

Always follow the directions for use.

ENQUIRY

Enquire About The PulseOn Arrhythmia Monitor

For clinical practices wishing to discuss bulk orders, purchase orders, or invoicing arrangements — please enquire below and we’ll respond within one business day.

ABOUT THE PULSEON

Objective Cardiac Monitoring
In and Out of the Clinic

The PulseOn Arrhythmia Monitor System assists in the diagnosis, screening and monitoring of atrial fibrillation and other cardiac arrhythmias visible in Lead I ECG. The wrist-worn device optically monitors pulse rate to detect possible atrial fibrillation and takes intermittent single-lead ECG measurements between the arms.

Measured data is stored on the device and transferred to a data management service where it can be analysed by medical professionals. The device can be used inside or outside a hospital environment for a usage period ranging from days to several weeks.

Capturing Episodic Cardiac Events Is One Of The 
Biggest Challenges In Cardiology.

Arrhythmias such as AFib are episodic — they occur intermittently and may pass before a patient reaches a clinic. A standard in-clinic ECG only captures what is happening at that specific moment. If the arrhythmia has already passed, the result comes back clear — even when the underlying problem is real.

PulseOn enables continuous monitoring over days or weeks. When a possible arrhythmia event occurs — including during sleep — the device captures it. The patient records a single-lead ECG on the spot, and the data is transferred for analysis by the treating clinician.

Who It’s For

  • Cardiologists and cardiac clinics

  • Stroke neurologists

  • General practitioners monitoring patients with suspected AFib

  • Hospitals and clinical cardiology departments

Rectangle 7 (3) (1).png

Key Features

Wrist-worn — no disturbance to daily life or sleep

Continuously monitors pulse rate to detect possible atrial fibrillation

Intermittent single-lead ECG (Lead I) recording

Data stored in an Australian-hosted cloud environment and transferred to management service for clinician review

Suitable for use inside or outside a hospital environment

Usage period from days to several weeks

HOW TO ORDER

Order Online or Request a Quote

Order online

Purchase the PulseOn Arrhythmia Monitor System directly through the CXDX online store. Payment upfront. Delivery: 13–20 business days from order date.

Request a quote or purchase order

For clinical practices requiring invoicing, purchase orders, or bulk orders — please enquire and we’ll respond within one business day.

DELIVERY INFORMATION

Order Processing & Delivery

  • Orders processed within 3–5 business days

  • Estimated delivery: 10–15 business days after processing

  • Total delivery time: generally 13–20 business days from order date

  • Delivery estimates may vary due to supplier, customs, or carrier delays

TRUST SIGNALS

Exclusive AU & NZ Distributor — Trusted by Clinicians Across Australia

TGA Registered Medical Device
The PulseOn Arrhythmia Monitor System is included in the Australian Register of Therapeutic Goods.
ARTG number: 519567. For use by medical professionals.

Exclusive AU & NZ Distributor — Local delivery, setup, training and ongoing support

Lake Macquarie Private Hospital logo (1).png
Newcastle Brain logo (1).png
Sydney Concussion Centre logo (1).png
Coastline Chiropractic logo (1).png
Power Potential logo (1).png

TEAM CREDENTIALS

Backed by Deep Clinical Expertise

NeuroTracker is available through CXDX as outright purchase or lease. Contact us with your requirements and we’ll facilitate a tailored quote directly from NeuroTracker.

image 22 (8) (1).png

Prof Michael Dirienzo

Chief Executive Officer. Former CEO, Hunter New England Health District — one of Australia’s largest health networks.

image 22 (9) (1).png

Dr Chris Levi

Chief Medical Officer. Stroke Neurologist and Director, John Hunter Health and Innovation Precinct, Newcastle.

bottom of page